Prospective study in 142 cases of hepatitis C virus infection

Table 1 Abnormal of serum alanine aminotransferase in pa-tients infected with HCV after 9 years’ follow-up in different groups

Group	Liver function
	Normal	Abnormal
	cases (%)	cases (%)
Anti-HCV(+)HCV RNA(+)	76 (69.72)	33 (30.28)
Anti-HCV(+)HCV RNA(-)	9 (90.00)	1 (10.00)
Anti-HCV(-)HCV RNA(+)	3 (100.0)	0
Anti-HCV(-)HCV RNA(-)	12 (100.0)	0
Anti-HCV(+)HCVRNA(undetected)	4 (50.00)	4 (50.00)
Total	104 (73.24)	38 (26.76)

Note: The number in the bracket is the percentage of normal and abnormal cases in each group.

Table 2 Comparison of ALT, AST, ALP, γ-GT, TBIL and DBIL between positive (+) and negative (-) HCV RNA patients (mean ± SE)

HCV RNA	Case	ALT (IU/L)	AST (IU/L)	ALP (IU/L)	γ-GT (IU/L)	Tbil (μmol/L)	DBiL (μmol/L)
+	112	31.2 ± 32.6b	34.8 ± 27.0b	82.0 ± 36.6	20.0 ± 17.6b	13.2 ± 5.6	6.0 ± 2.3
-	22	16.1 ± 8.6	22.9 ± 6.5	78.9 ± 40.1	12.4 ± 5.8	12.1 ± 7.4	5.4 ± 2.2

^bP < 0.001 vs the negative group of HCV RNA.